top of page
Contract Year 2027 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Program (Part c and D proposed rule)
This letter outlines MMAPA´s comments on the 2027 Medicare Advantage and Part D Final Rule, with particular emphasis on policies affecting Puerto Rico. It discusses the importance of preserving flexibility for Dual Eligible Special Needs Plans (D-SNPs), maintaining beneficiary choice, and ensuring federal policies support a stable and competitive Medicare Advantage program on the Island.
MMAPA´s comments on the CY 2027 Medicare Advantage Advance Notice
MMAPA´s comments on the CY 2027 Medicare Advantage Advance Notice In this document, MMAPA outlines its recommendations to CMS on proposed Medicare Advantage payment and policy changes for 2027. The comments explain how federal payment decisions affect Puerto Rico´s healthcare system and offer practical recommendations to help preserve beneficiary choice, strengthen program stability, and support continued access to high-quality care on the Island.
MMAPA letter to CMS regarding D-SNP
Letter to CMS on Protecting Choice for Puerto Rico´s Dual-Eligible Beneficiaries This letter outlines MMAPA´s recommendations to CMS to preserve beneficiary choice and competition within Puerto Rico´s integrated Medicare-Medicaid program. It explains why maintaining multiple D-SNP benefit options is essential to protecting a highly successful model of coordinated care that serves more than 300,000 dual-eligible beneficiaries while advancing CMS´s goals of integration, quality
bottom of page


